No Data
No Data
Sector Update: Health Care Stocks Decline Tuesday Afternoon
Silexion Therapeutics Stock Trades Higher, Trial Data For Pancreatic Cancer Patients Shows Promise
Express News | Silexion Therapeutics Corp - Progressing With Development of Next-Gen Product Sil-204
Silexion Therapeutics Announces Significant New Data From Phase 2 Trial of LODER in Non-Resectable Pancreatic Cancer
Express News | Silexion Therapeutics Corp: Announces Significant New Data From Phase 2 Trial of Loder™ in Non-Resectable Pancreatic Cancer
Top Premarket Gainers
No Data
No Data
72768766 : Lots of downward movement